Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Observational pediatric nadroparin PK/PD study
NL-OMON57402Recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jun 2025
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of nadroparin in venous thromboembolism (VTE) (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoints: Evidence-based therapeutic dosing regimens by age group and Evidence-based prophylactic dosing regimens by age group. Started Jun 2025; status: recruiting.
02
Drugs
nadroparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NL-OMON57402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON57402.